MFN2 and obesity disorder: The co‐IP assay in human myocardium revealed decreased binding of Mfn2 with Hsc70 in the hearts of patients with obesity (Figure 8K), which was associated with increased Mfn2 acetylation and ubiquitylation (Figure 8L,M).